ARTICLE

FindCenter AddIcon

Repeated Ketamine Infusions Reduce PTSD Symptom Severity

By ScienceDaily — 2021

Repeated intravenous (IV) ketamine infusions significantly reduce symptom severity in individuals with chronic post-traumatic stress disorder (PTSD) and the improvement is rapid and maintained for several weeks afterwards, according to a new study.

Read on www.sciencedaily.com

FindCenter Post-Image

FDA Calls Psychedelic Psilocybin a 'Breakthrough Therapy' for Severe Depression

The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).

Article
Yasemin Saplakoglu
2019
FindCenter AddIcon
FindCenter Post-Image

What Psychedelic Mushrooms Are Teaching Us About Human Consciousness

Psychedelic drugs like psilocybin are being tested to treat mental illness. They're also expanding our understanding about human consciousness.

Article
Iris Kulbatski
2020
FindCenter AddIcon
FindCenter Post-Image

Meet the Psychologist Using Psychedelics to Treat Racial Trauma

People of color are dealing with racism all the time, in large and small ways, and even dealing with racism in healthcare, even dealing with racism in therapy.

Article
Robin Donovan
2021
FindCenter AddIcon
FindCenter Post-Image

How Should We Do Drugs Now?

While we can now begin to glimpse an end to the drug war, it is much harder to envision what the drug peace will look like. How will we fold these powerful substances into our society and our lives so as to minimize their risks and use them most constructively?

Article
Michael Pollan
2021
FindCenter AddIcon
FindCenter Post-Image

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.

After decades of demonization and criminalization, psychedelic drugs are on the cusp of entering mainstream psychiatry, with profound implications for a field that in recent decades has seen few pharmacological advancements for the treatment of mental disorders and addiction.

Article
Andrew Jacobs
2021
FindCenter AddIcon
FindCenter Post-Image

The Trip Treatment

Research into psychedelics, shut down for decades, is now yielding exciting results.

Article
Michael Pollan
2015
FindCenter AddIcon
FindCenter Post-Image

Why Canada Could Be Next to Allow Psychedelic Therapy (And How It’s Already Changing Lives)

Now, as a handful of patients and more recently doctors and therapists have been granted exemptions to use psilocybin, the nation’s federal health agency is considering making changes to existing policies that could open the door to much more than magic mushrooms.

Article
Amanda Siebert
2020
FindCenter AddIcon
FindCenter Post-Image

How Ecstasy and Psilocybin Are Shaking Up Psychiatry

Regulators will soon grapple with how to safely administer powerful psychedelics for treating depression and post-traumatic stress disorder.

Article
Paul Tullis
2021
FindCenter AddIcon
FindCenter Post-Image

Johns Hopkins Scientists Give Psychedelics the Serious Treatment

Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look.

Article
Tanya Lewis
2020
FindCenter AddIcon
FindCenter Post-Image

My Adventures with the Trip Doctors

My first psilocybin journey began around an altar in the middle of a second-story loft in a suburb of a small city on the Eastern Seaboard.

Article
Michael Pollan
2018
FindCenter AddIcon

EXPLORE TOPIC

Ketamine